These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11480224)

  • 1. Abuse liability of diazepam through different routes.
    Singh RK; Jain R; Ray R; Gupta YK
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):181-90. PubMed ID: 11480224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of diazepam and oxazepam: preference, liking and extent of abuse.
    Griffiths RR; McLeod DR; Bigelow GE; Liebson IA; Roache JD; Nowowieski P
    J Pharmacol Exp Ther; 1984 May; 229(2):501-8. PubMed ID: 6716272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abuse liability of buprenorphine--a study among experienced drug users.
    Bedi NS; Ray R; Jain R; Dhar NK
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):95-100. PubMed ID: 9513799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users.
    Zacny JP; Gutierrez S; Bolbolan SA
    Drug Alcohol Depend; 2005 Jun; 78(3):243-52. PubMed ID: 15893155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse liability assessment of atomoxetine in a drug-abusing population.
    Jasinski DR; Faries DE; Moore RJ; Schuh LM; Allen AJ
    Drug Alcohol Depend; 2008 May; 95(1-2):140-6. PubMed ID: 18328639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the abuse potential of pagoclone, a partial GABAA agonist.
    de Wit H; Vicini L; Haig GM; Hunt T; Feltner D
    J Clin Psychopharmacol; 2006 Jun; 26(3):268-73. PubMed ID: 16702891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug preferences in humans.
    Johanson CE; Uhlenhuth EH
    Fed Proc; 1982 Feb; 41(2):228-33. PubMed ID: 7060750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative abuse liability of different benzodiazepines in drug abusers.
    Griffiths RR; Wolf B
    J Clin Psychopharmacol; 1990 Aug; 10(4):237-43. PubMed ID: 1981067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
    Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
    J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans.
    Busto U; Kaplan HL; Zawertailo L; Sellers EM
    Clin Pharmacol Ther; 1994 Apr; 55(4):451-63. PubMed ID: 8162672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men.
    Ciraulo DA; Barnhill JG; Greenblatt DJ; Shader RI; Ciraulo AM; Tarmey MF; Molloy MA; Foti ME
    J Clin Psychiatry; 1988 Sep; 49(9):333-7. PubMed ID: 3417618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between objective psychomotor impairment and subjective sleepiness after diazepam administration in the aged people.
    Echizenya M; Mishima K; Satoh K; Kusanagi H; Ohkubo T; Shimizu T
    Hum Psychopharmacol; 2007 Aug; 22(6):365-72. PubMed ID: 17562526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal.
    Jaffe JH; Ciraulo DA; Nies A; Dixon RB; Monroe LL
    Clin Pharmacol Ther; 1983 Nov; 34(5):623-30. PubMed ID: 6627822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans.
    Marsch LA; Bickel WK; Badger GJ; Rathmell JP; Swedberg MD; Jonzon B; Norsten-Höög C
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1056-65. PubMed ID: 11714895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of diazepam and mood ratings.
    Ghoneim MM; Mewaldt SP; Ambre J
    Anesth Analg; 1975; 54(2):173-7. PubMed ID: 1168423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reinforcing and subjective effects of the volatile anesthetic, sevoflurane.
    Walker DJ; Beckman NJ; Zacny JP
    Drug Alcohol Depend; 2004 Nov; 76(2):191-201. PubMed ID: 15488343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative abuse liability of lorazepam and diazepam: an evaluation in 'recreational' drug users.
    Funderburk FR; Griffiths RR; McLeod DR; Bigelow GE; Mackenzie A; Liebson IA; Nemeth-Coslett R
    Drug Alcohol Depend; 1988 Dec; 22(3):215-22. PubMed ID: 3234245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.